JenKem Technology and Merck Announce Distribution Agreement for PEG Products
September 19, 2016
JenKem Technology Co., Ltd.
JenKem Technology and the life science business of Merck are pleased to announce a collaboration agreement for the distribution of select JenKem Technology high quality polyethylene glycol (PEG) products for biomedical applications by Merck.
JenKem Technology’s PEG products are widely used for drug delivery and hydrogel manufacturing in the pharmaceutical, biotechnology, medical device, diagnostics, and emerging chemical specialty markets. The distribution agreement allows Merck to introduce and market JenKem Technology’s portfolio of PEG products to their existing customer base. Merck’s global distribution infrastructure will allow small volume PEG users convenient access to select JenKem® PEG products, such as Y-Shape PEGs, Methoxy PEGs, and Monodisperse PEGs for PEGylation, Homobifunctional PEGs, Heterobifunctional and Multi-arm Heterobifunctional PEG linkers for ADCs and other applications, Multi-arm PEGs for hydrogels, and Biodegradable PEG Co-Polymers for controlled release drug delivery. JenKem® PEG products sold by Merck will contain the statement “Product of JenKem Technology” on the product label whenever possible and on Merck’s website, www.sigma-aldrich.com, and other promotional materials. JenKem Technology’s products will be marketed under the Aldrich® brand in Merck’s Sigma-Aldrich catalog.
“It is a great opportunity to partner with Merck to allow JenKem® PEGs to become more widely available to researchers in the biomedical field. The arrangement with Merck allows us to leverage Merck’s substantial relationships and infrastructure within the biomedical and related industries” says JenKem Technology’s VP of Business Development, Dr. Mark Frishberg.
With strategic international locations, Merck will offer JenKem Technology worldwide coverage, local sales force, and superior logistics. Merck will hold inventory of JenKem PEGS and ship direct using their excellent logistics systems. JenKem Technology Co., Ltd. and JenKem Technology USA, Inc., the sales subsidiary of JenKem Technology Co. Ltd., will continue to provide sales of PEG products and PEGylation services in small research scale where a customer chooses to work directly with JenKem Technology, and for bulk and commercial scale non-GMP and GMP grade products. Products distributed by JenKem Technology Co. Ltd. and JenKem Technology USA, Inc. will continue to be shipped to the customer directly from the JenKem Technology Co. Ltd.’s manufacturing facilities in Beijing and Tianjin P.R. China.
About JenKem Technology
JenKem Technology Co., Ltd. is a private chemical company with headquarters and R&D in Beijing, and scale-up and commercial quantities manufacturing in Tianjin, P.R. China. JenKem Technology Co., Ltd. focuses on the development and manufacturing of high quality polyethylene glycol (PEG) products and derivatives, and related custom synthesis and PEGylation services. JenKem Technology Co. Ltd. caters to the PEG derivative and PEGylation needs of the pharmaceutical, biotechnology, medical device and diagnostics, and emerging chemical specialty markets, from laboratory scale through commercial scale. JenKem Technology performs all of its polymerizations internally through access to ethylene oxide which helps maintain excellent batch to batch consistency and narrow polydispersity. For more information, please visit the website of JenKem Technology USA, Inc., the sales subsidiary of JenKem Technology Co. Ltd., at https://www.jenkemusa.com.
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of €12.85 billion in 66 countries.
Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. The company holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Company Information and Sales Related Inquiries:
Contact: Daniela Hutanu, PhD
Manager, Marketing and Sales
JenKem Technology USA
4105 W. Spring Creek Pkwy, Suite #606B
Plano, TX 75024, USA
Jansen Xu 徐锦承
Head of Communications, Performance Materials and Life Science
Merck Holding China
Tower 2, No.88 Chenhui Road
Tel: +86 (0)21 2033 8299
www.merck.com.cn or www.merckmillipore.com